within Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A10B_BloodGlucoseLoweringDrugsExclInsulins.A10BB07_Glipizide;

model Glipizide
  extends Pharmacolibrary.Drugs.ATC.A.A10BB07;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>A10BB07</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Glipizide is an oral sulfonylurea antidiabetic drug used in the management of type 2 diabetes mellitus. It stimulates insulin secretion by the pancreas and is approved for use worldwide.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers after oral administration; mixed sexes; single-dose study.</p><h4>References</h4><ol><li><p>Kosoglou, T, et al., &amp; Alton, KB (2005). Ezetimibe: a review of its metabolism, pharmacokinetics and drug interactions. <i>Clinical pharmacokinetics</i> 44(5) 467–494. DOI:<a href=\"https://doi.org/10.2165/00003088-200544050-00002\">10.2165/00003088-200544050-00002</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/15871634/\">https://pubmed.ncbi.nlm.nih.gov/15871634</a></p></li><li><p>Wensing, G (1989). Glipizide: an oral hypoglycemic drug. <i>The American journal of the medical sciences</i> 298(1) 69–71. DOI:<a href=\"https://doi.org/10.1097/00000441-198907000-00012\">10.1097/00000441-198907000-00012</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/2665487/\">https://pubmed.ncbi.nlm.nih.gov/2665487</a></p></li><li><p>Prendergast, BD (1984). Glyburide and glipizide, second-generation oral sulfonylurea hypoglycemic agents. <i>Clinical pharmacy</i> 3(5) 473–485. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/6435940/\">https://pubmed.ncbi.nlm.nih.gov/6435940</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Glipizide;
